SCHEMBL6618812

SCHEMBL6618812

COc1cccc(OC)c1-c1cnc2cc3cn[nH]c3cc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ TLR8 Q9NR97 1/20 0.46
▸ AXL P30530 1/20 0.46
▸ TRPA1 O75762 1/20 0.42
▸ TRPM8 Q7Z2W7 1/20 0.42
▸ FGFR1 P11362 1/20 0.40
▸ FGFR2 P21802 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.39
▸ ATR Q13535 1/20 0.39
▸ MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6616668 1.00 ALDH1A1 (0.47) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL8143522 0.91 GAA (0.45) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL6618763 0.81 MAP3K11 (0.55) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL6618374 0.81 MAP3K11 (0.55) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL6616674 0.80 FGFR1 (0.48) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL6620076 0.80 FGFR1 (0.48) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL6616655 0.79 TLR8 (0.46) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL6620516 0.79 TLR8 (0.46) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL9133723 0.78 PDGFRB (0.51) ALDH1A1GLAGAAMAPTSMN1; SMN2
SCHEMBL6618595 0.78 PDGFRB (0.51) ALDH1A1GLAGAAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 — — EP disclosed
EP-0779889-A4 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE POULENC RORER PHARMA (US) 2000-02-23 — — EP disclosed
EP-0779889-A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-06-25 — — EP disclosed
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 — — WO disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 — — US disclosed
Send feedback